4.2 Article

Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia

Journal

HEMATOLOGY
Volume 26, Issue 1, Pages 444-446

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/16078454.2021.1929694

Keywords

Myelodysplastic syndrome; pure red cell aplasia; diagnosis; prognosis; drug therapy; cyclosporine; glucocorticoids; androgen; sirolimus

Categories

Funding

  1. National Natural Science Foundation of China [81970115, 81970116, 81800119]
  2. Key Technology Research and Development Program of Tianjin China [18ZXDBSY00140]

Ask authors/readers for more resources

The study identified 6 cases of low- and intermediate-risk MDS patients with PRCA, showing difficult treatment but a good prognosis.
Objectives: Our aim is to investigate the clinical characteristics of low- and intermediate-risk myelodysplastic syndrome (MDS) with pure red cell aplasia (PRCA). Methods: We retrospectively reviewed the patients of low- and intermediate-risk MDS patients who had been diagnosed with PRCA in our hospital between January 2010 and December 2019. Results: There were 6 low- and intermediate-risk MDS patients with PRCA in our study, 1 male and 5 females, with a median age of 63.5 (50-75) years. It accounted for 7.7% (6/78) of all diagnosed PRCA cases and 1.67% (6/359) of diagnosed MDS cases during the same period. All patients were treated with multiple drugs, including recombinant human erythropoietin, cyclosporine, glucocorticoids, androgen, sirolimus, intravenous immunoglobulin and decitabine. Two patients achieved complete remission, two patients achieved partial remission and became blood transfusion independent. Two patients had no response and one patient died. Conclusion: Low- and intermediate-risk MDS with PRCA was difficult to treat, but the prognosis was good.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available